CyDex Pharmaceuticals Hires Vice President, Business Development and Marketing.Ralph S. Johnston Will Lead Company's Strategic Partnership Initiatives LENEXA, Kan. -- CyDex Pharmaceuticals, Inc. today announced that Ralph S. Johnston has been named as the company's vice president, business development and marketing. Mr. Johnston will report directly to Theron E. Odlaug, CyDex president and chief executive officer. In this newly created position, Johnston will play a lead role in CyDex's strategic effort to develop and market low-risk proprietary products that target unmet needs in hospital intravenous acute care. In addition, he will be responsible for increasing the potential for new technology licensing agreements and limited clinical use agreements, enhancing the company's intellectual property portfolio, and facilitating contract negations for in- and out-licensing product opportunities. "Ralph brings more than 20 years of pharmaceutical industry experience to CyDex," said Odlaug. "He has a proven record of success in establishing partnerships and developing new business opportunities in senior leadership roles at pharmaceutical and medical device companies such as Pfizer and Elan Pharmaceuticals. We look forward to having Ralph on the CyDex team as we expand our CAPTISOL([R]) technology licensing business and develop our proprietary product pipeline." Prior to joining CyDex, Johnston was senior vice president, chief commercial officer at Intranasal in·tra·na·sal adj. Within the nose. Therapeutics, where he was responsible for repositioning repositioning Laparoscopic surgery The changing of a Pt's position during a procedure to improve access or visualization of the operative field, which may be linked to complications, as it changes anatomic planes of operation. Cf Laparoscopic surgery. the company and identifying new development and commercial partners for nasal drug products. He previously was co-founder and president of Contour Medical, a drug delivery company. Prior to Contour, he was vice president, marketing and business development at Elan Pharmaceuticals, and vice president, sales and marketing at Pfizer Infusaid. Johnston received a bachelor's degree in biology and chemistry from Eastern Michigan University Eastern Michigan University, mainly at Ypsilanti, Mich.; coeducational; founded 1849 as a normal school, became Eastern Michigan College in 1956, gained university status in 1959. and a master's degree master's degree n. An academic degree conferred by a college or university upon those who complete at least one year of prescribed study beyond the bachelor's degree. Noun 1. in business administration from Suffolk University During the 1990s Suffolk University constructed its first residence halls, began satellite programs with other colleges in Massachusetts, and opened campuses in both Madrid, Spain, and Dakar, Senegal, (the Suffolk University Dakar Campus). . About CyDex Pharmaceuticals CyDex Pharmaceuticals, Inc. is a specialty pharmaceutical company developing products and licensing its CAPTISOL([R]) enabling technology. CyDex is developing its own pipeline of products using its enabling technology solutions, and partnering with leading pharmaceutical, specialty pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. . CyDex is a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. located in suburban Kansas City Kansas City, two adjacent cities of the same name, one (1990 pop. 149,767), seat of Wyandotte co., NE Kansas (inc. 1859), the other (1990 pop. 435,146), Clay, Jackson, and Platte counties, NW Mo. (inc. 1850). . To learn more about the company, please visit www.cydexpharma.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion